Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-01

FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

The FDA approved a supplemental application for HALOPERIDOL DECANOATE by Fresenius Kabi USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL DECANOATE (Haloperidol decanoate)

Snippet

SUPPL AP for HALOPERIDOL DECANOATE (HALOPERIDOL DECANOATE)